LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival-Reference-Cited by-同舟云学术

LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival

Published:2021-02 Issue: Volume:498 Page:165-177
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Peng Li-Xia,Wang Ming-Dian,Xie Ping,Yang Jun-Ping,Sun Rui,Zheng Li-Sheng,Mei Yan,Meng Dong-Fang,peng Xing-Si,Lang Yan-Hong,Qiang Yuan-Yuan,Li Chang-Zhi,Xu Liang,Liu Zhi-Jie,Guo Ling-Ling,Xie De-Huan,Shu Di-Tian,Lin Si-Ting,Luo Fei-Fei,Huang Bi-Jun,Qian Chao-Nan

Funder

National Natural Science Foundation of China

Science and Technology Planning Project of Guangdong Province

Natural Science Foundation of Guangdong, China

Provincial Natural Science Foundation of Fujian, China

Sun Yat-sen University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference55 articles.

1. Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis;Liao;Canc. Commun.,2019